As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Study Identifies Potential New Drug for Parkinson's-Related Cognitive Decline, Dementia Nov ... which could lead to treatments for the cognitive symptoms of Parkinson's ... Asthma May Place ...